Effect of human Noxa on irinotecan-induced apoptosis in human gastric carcinoma cell lines

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 912-915

  Sasaki, Takamitsu ^a   Sasahira, Tomonori ^a   Shimura, Hideo ^b   Ikeda, Seiyo ^b   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2 family; Gastric cancer; Noxa; P53

Indexed keywords

BH3 PROTEIN; DNA FRAGMENT; IRINOTECAN; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; PROTEIN; PROTEIN NOXA; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; WILD TYPE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CELL LINE, TUMOR; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 2342467366     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Vousden KH, Lu X: Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2:594-604.
2. Ko LJ, Prives C: p53: puzzle and paradigm. Genes Dev 1996; 10:1054-1072.
3. Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW: Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002; 1:289-298.
4. Lowe SW: Cancer therapy and p53. Curr Opin Oncol 1995; 7:547-553.
5. Sionov RV, Haupt Y: The cellular response to p53: the decision between life and death. Oncogene 1999; 18:6145-6157.
6. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW: Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 1999; 284:156-159.
7. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-730.
8. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288:1053-1058.
9. Hijikata M, Kato N, Sato T, Kagami Y, Shimotohno K: Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate- responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol 1990; 64:4632-4639.
10. Ochiai A, Yasui W, Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 1985; 76:1064-1071.
11. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991; 51:381-386.
12. Akama Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T, Tahara E: Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87:824-830.
13. Yokozaki H, Kuniyasu H, Shuho S, Yasui W, Tahara E: Molecular bases of human stomach carcinogenesis. In: Tahara E (Ed.). Molecular pathology of gastroenterological cancer. Tokyo: Springer-Verlag, 1997; pp. 55-70.
14. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988, 48:589-601.
15. Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303.
16. Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-299.
17. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000; 408:307-310.
18. Fritsche M, Haeesler C, Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993; 8:307-318.
19. Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 1994; 14:1815-1823.